Tiziana Life Sciences Ltd (TLSA) Stock Price, Quote & News

Company Profile

Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 44 20 7495 2379

Website: www.tizianalifesciences.com

Address:

14/15 Conduit Street, London, United Kingdom

Rick_Morty Mar. 20 at 1:57 PM

$SMCI almost as bad as $TLSA and $META

1 · Reply

Housatonic1864 Mar. 20 at 10:34 AM

$TLSA get ready🫡

0 · Reply

NSAR Mar. 20 at 12:02 AM

$TLSA I think this company has a ton of potential and their data so far is extremely encouraging my only question or we can call it frustration is that they don’t have an earnings call. Has anybody been able to participate in their earnings call? has anybody been able to reach a person in investor relations or get even a reply via email?

0 · Reply

sister Mar. 19 at 7:51 PM

$UCAR Shorts have to cover or risk this opening tomorrow .75 cents or higher. Was $1.75 on Tuesday $TLSA $RIVN

1 · Reply

rispi Mar. 19 at 7:10 PM

$TLSA When is next readout scheduled?

1 · Reply

Housatonic1864 Mar. 18 at 5:02 PM

$TLSA Goldman Sachs increased its stake within the ticker. They know something’s brewing 🫡

1 · Reply

Housatonic1864 Mar. 18 at 10:21 AM

$TLSA keep a close eye on this ticker. It’s teetering, about to pop. Trade the dips😂

0 · Reply

WHATABOUTSTOCKS Mar. 17 at 9:32 PM

$TLSA probably more delays here.

0 · Reply

Airforcecaptain Mar. 17 at 7:46 PM

$TLSA I saw a comment by the CEO on Linkedin last night. He said he wanted to join another company. But now, it’s gone. I don’t know what to make of it. Any thoughts?

3 · Reply

FarrUkk Mar. 17 at 6:38 PM

$DJT $SPY $TRUMP.X $MELANIA.X $TLSA Chewing gum for noodle $NUMBNUTTZIES https://m.youtube.com/watch?v=aQSDSqdlFxk

0 · Reply

Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA

Jan 20, 2026, 11:15 AM EST - 2 months ago

Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab

Jan 16, 2026, 2:45 PM EST - 2 months ago

Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares

Jan 16, 2026, 7:00 AM EST - 2 months ago

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million

Jan 9, 2026, 7:00 AM EST - 2 months ago

Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco

Dec 29, 2025, 8:00 AM EST - 2 months ago

Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA

Dec 19, 2025, 11:00 AM EST - 3 months ago

Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman

Dec 17, 2025, 10:00 AM EST - 3 months ago

Tiziana Life Sciences to Ring the Closing Bell at Nasdaq

Dec 17, 2025, 8:45 AM EST - 3 months ago

Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer's Clinical Trial

Dec 15, 2025, 3:07 PM EST - 3 months ago

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer

Dec 15, 2025, 7:30 AM EST - 3 months ago

Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering

Dec 12, 2025, 2:10 PM EST - 3 months ago

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial

Dec 2, 2025, 7:00 AM EST - 3 months ago

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

Nov 25, 2025, 8:30 AM EST - 4 months ago

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

Nov 13, 2025, 8:30 AM EST - 4 months ago

Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference

Oct 29, 2025, 7:00 AM EDT - 5 months ago

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy

Sep 30, 2025, 8:30 AM EDT - 6 months ago

Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia

Sep 24, 2025, 8:30 AM EDT - 6 months ago

Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress

Sep 15, 2025, 8:00 AM EDT - 6 months ago

Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury

Sep 5, 2025, 8:30 AM EDT - 7 months ago

Tiziana Life Sciences Announces Purchase of Shares by Chairman

Aug 14, 2025, 8:30 AM EDT - 7 months ago

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy

Aug 11, 2025, 9:00 AM EDT - 7 months ago

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

Jul 21, 2025, 7:00 AM EDT - 8 months ago

Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient

Jun 13, 2025, 10:30 AM EDT - 10 months ago

Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

Jun 13, 2025, 8:30 AM EDT - 10 months ago

Tiziana Life Sciences to Present at the Bio International Convention

May 23, 2025, 7:00 AM EDT - 10 months ago

Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer's Disease

May 15, 2025, 8:00 AM EDT - 11 months ago

Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease

May 9, 2025, 7:00 AM EDT - 11 months ago

Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab

May 6, 2025, 7:00 AM EDT - 11 months ago

Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis

Apr 23, 2025, 7:00 AM EDT - 11 months ago

Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial

Apr 2, 2025, 8:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial

Mar 25, 2025, 8:00 AM EDT - 1 year ago

Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial

Mar 17, 2025, 8:00 AM EDT - 1 year ago

Tiziana Life Sciences to Present at the 37th Annual Roth Conference

Mar 14, 2025, 8:30 AM EDT - 1 year ago

Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule

Mar 4, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial

Feb 27, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Groundbreaking Study Published in Nature Neuroscience Demonstrating Positive Results for Nasal Anti-CD3 Therapy in Traumatic Brain Injury

Feb 25, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Long Covid Study to Complete in Second Quarter

Feb 21, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC

Feb 18, 2025, 8:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Dosing of Additional Patients in Multiple Sclerosis Expanded Access Program

Feb 11, 2025, 9:15 AM EST - 1 year ago

Tiziana Life Sciences Announces TV Interview with First Patient Dosed with Moderate Alzheimer's Disease

Jan 23, 2025, 3:00 PM EST - 1 year ago

Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-CD3

Jan 23, 2025, 8:54 AM EST - 1 year ago

Tiziana Life Sciences not to engage in capital raising activities for the immediate future

Jan 22, 2025, 4:05 PM EST - 1 year ago

Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab

Jan 8, 2025, 7:00 AM EST - 1 year ago

Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease

Nov 1, 2024, 1:00 PM EDT - 1 year ago

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent Clinical Advancements, Including Positive GLP-1 Combination Study Data

Oct 30, 2024, 10:29 PM EDT - 1 year ago

Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $10 Million

Aug 19, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Appoints New Chief Executive Officer

Jul 24, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences Granted FDA Fast Track Designation

Jun 28, 2024, 11:01 AM EDT - 1 year ago

Tiziana Receives $3.4 Million in Non-Dilutive Funding

Jun 26, 2024, 7:00 AM EDT - 1 year ago

Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer's Disease with Foralumab

Rick_Morty Mar. 20 at 1:57 PM

$SMCI almost as bad as $TLSA and $META

1 · Reply

Housatonic1864 Mar. 20 at 10:34 AM

$TLSA get ready🫡

0 · Reply

NSAR Mar. 20 at 12:02 AM

0 · Reply

sister Mar. 19 at 7:51 PM

$UCAR Shorts have to cover or risk this opening tomorrow .75 cents or higher. Was $1.75 on Tuesday $TLSA $RIVN

1 · Reply

rispi Mar. 19 at 7:10 PM

$TLSA When is next readout scheduled?

1 · Reply

Housatonic1864 Mar. 18 at 5:02 PM

$TLSA Goldman Sachs increased its stake within the ticker. They know something’s brewing 🫡

1 · Reply

Housatonic1864 Mar. 18 at 10:21 AM

$TLSA keep a close eye on this ticker. It’s teetering, about to pop. Trade the dips😂

0 · Reply

WHATABOUTSTOCKS Mar. 17 at 9:32 PM

$TLSA probably more delays here.

0 · Reply

Airforcecaptain Mar. 17 at 7:46 PM

$TLSA I saw a comment by the CEO on Linkedin last night. He said he wanted to join another company. But now, it’s gone. I don’t know what to make of it. Any thoughts?

3 · Reply

FarrUkk Mar. 17 at 6:38 PM

$DJT $SPY $TRUMP.X $MELANIA.X $TLSA Chewing gum for noodle $NUMBNUTTZIES https://m.youtube.com/watch?v=aQSDSqdlFxk

0 · Reply

Housatonic1864 Mar. 17 at 3:05 PM

$TLSA need a PR about now🫡

0 · Reply

Gegau001 Mar. 17 at 11:48 AM

$TLSA Good news is very close, I can practically smell it 🙋✌️

1 · Reply

Housatonic1864 Mar. 16 at 6:29 PM

$TLSA the beginning has begun😂

0 · Reply

Housatonic1864 Mar. 16 at 4:32 PM

$TLSA if you take a look at $TLSA and it’s history before the big news, you’d see something is taking place that will be magnificent with the ticker. If you’re looking for a good growth opportunity, this is it. Sit back and ride the waves🏴‍☠️

0 · Reply

Housatonic1864 Mar. 16 at 3:44 PM

$TLSA I like it😂

0 · Reply

Housatonic1864 Mar. 16 at 2:29 PM

$TLSA PR please 🙏

0 · Reply

rp6577 Mar. 13 at 5:22 PM

$TLSA might have to add a bit more at these prices 🤔

1 · Reply

Housatonic1864 Mar. 13 at 2:26 PM

$TLSA we need a positive PR before the EPS report.

0 · Reply

Bstyle13 Mar. 13 at 3:33 AM

$TLSA

1 · Reply

Zenlama Mar. 11 at 2:53 PM

$TLSA https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-03-09-2026/card/biotech-stocks-rally-on-departure-of-polarizing-fda-official-MSjPZ3XhEXbEOrftphiC?mod=mhp

0 · Reply

Zenlama Mar. 11 at 2:47 PM

$TLSA Dr. Vinay Prasad, of the FDA, is finally out! So many biotechs have been stifled by him. I see a Renaissance in biotech about to begin. GLTA

1 · Reply

Market Cap	153.98M
Revenue (ttm)	0.00
Net Income (ttm)	-11.86M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	101,300
Avg Vol	205,848
Day's Range	N/A - N/A
Shares Out	127.26M
Stochastic %K	5%
Beta	0.22
Analysts	Strong Sell
Price Target	$8.00